Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 5 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
High frequency of hyperglycaemia observed during CAR T-cell treatment.
Diabet Med. 2023 Feb;40(2):e14969. doi: 10.1111/dme.14969. Epub 2022 Oct 17.
Diabet Med. 2023.
PMID: 36209376
Free PMC article.
No abstract available.
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
Keijzer K, de Boer JW, van Doesum JA, Noordzij W, Huls GA, van Dijk LV, van Meerten T, Niezink AGH.
Keijzer K, et al. Among authors: de boer jw.
Blood Cancer J. 2024 Mar 7;14(1):41. doi: 10.1038/s41408-024-01022-w.
Blood Cancer J. 2024.
PMID: 38448432
Free PMC article.
Item in Clipboard
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Spanjaart AM, Pennings ERA, Mutsaers PGNJ, van Dorp S, Jak M, van Doesum JA, de Boer JW, Niezink AGH, Kos M, Vermaat JSP, Sijs-Szabo A, van der Poel MWM, Nijhof IS, Kuipers MT, Chamuleau MED, Lugtenburg PJ, Doorduijn JK, Serroukh YIM, Minnema MC, van Meerten T, Kersten MJ; Dutch CAR-T Tumorboard Consortium.
Spanjaart AM, et al. Among authors: de boer jw.
Cancers (Basel). 2023 Aug 30;15(17):4334. doi: 10.3390/cancers15174334.
Cancers (Basel). 2023.
PMID: 37686611
Free PMC article.
Item in Clipboard
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
de Boer JW, Pennings ERA, Kleinjan A, van Doesum JA, Spanjaart AM, Mutsaers PGNJ, Jak M, van der Poel MWM, Kuipers MT, Adam JA, Diepstra A, Koens L, van Dorp S, Vermaat JSP, Niezink AGH, Kersten MJ, van Meerten T.
de Boer JW, et al.
Blood Adv. 2023 Nov 14;7(21):6710-6716. doi: 10.1182/bloodadvances.2023010665.
Blood Adv. 2023.
PMID: 37639324
Free PMC article.
No abstract available.
Item in Clipboard
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation.
Keijzer K, Niezink AGH, de Boer JW, van Doesum JA, Noordzij W, van Meerten T, van Dijk LV.
Keijzer K, et al. Among authors: de boer jw.
Comput Struct Biotechnol J. 2023 Jan 20;21:1102-1114. doi: 10.1016/j.csbj.2023.01.023. eCollection 2023.
Comput Struct Biotechnol J. 2023.
PMID: 36789266
Free PMC article.
Item in Clipboard
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
de Boer JW, Keijzer K, Pennings ERA, van Doesum JA, Spanjaart AM, Jak M, Mutsaers PGNJ, van Dorp S, Vermaat JSP, van der Poel MWM, van Dijk LV, Kersten MJ, Niezink AGH, van Meerten T; Dutch CAR-T Tumorboard Consortium.
de Boer JW, et al.
Cancers (Basel). 2023 Nov 16;15(22):5443. doi: 10.3390/cancers15225443.
Cancers (Basel). 2023.
PMID: 38001703
Free PMC article.
Item in Clipboard
Cite
Cite